AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 84 filers reported holding AMRYT PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,021 | – | 70,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $64,658,056 | 27.18% |
| Stonepine Capital Management, LLC | 6,333,239 | $46,232,645 | 19.45% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $19,482,554 | 8.15% |
| Aquilo Capital Management, LLC | 2,098,993 | $15,322,649 | 5.76% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,283,080 | 2.38% |
| Global Frontier Investments LLC | 505,000 | $3,687 | 1.62% |
| Telemetry Investments, L.L.C. | 130,262 | $951 | 1.50% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $46,235 | 1.27% |
| Rubric Capital Management LP | 3,600,000 | $26,280,000 | 1.15% |
| Clearline Capital LP | 631,942 | $4,613,176 | 0.82% |